Wednesday, 19 June 2019

China News

  • Menarini to market Moberg nails in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

    Singapore: Menarini Asia Pacific has been granted exclusive rights to market and sell Moberg Pharma's Kerasal Nail in China. The companies now intend to seek marketing authorization for the...Read more

  • Dr Ling Su is new DIA board president

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

    Singapore: DIA, the premier organization dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide, has appointed Dr Ling Su as the presi...Read more

  • BGI-Shenzhen extends acquisition date of Complete

    China |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

    Singapore: BGI-Shenzhen's wholly owned subsidiary, Beta Acquisition, extended its all cash tender offer to purchase all outstanding shares of common stock of US-based Complete Genomics to 1...Read more

  • 3SBio to merge with Decade Sunshine

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2013

    Singapore: China-based 3SBio entered into an agreement and plan-of-merger with Decade Sunshine, an exempted company with limited liability incorporated under the laws of the Cayman Islands...Read more

  • APAC healthcare industry becomes cloud friendly

    China |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is embracing the full gamut of cloud provided services from infrastructure...Read more

  • Material science firm Crystal to open lab in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

    Singapore: Crystal Pharmatech is going to open its laboratories in China in order to provide customized, materials science development service packages in drug R&D. Crystal has adopte...Read more

  • Mindray re-elects its directors

    China |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

    Singapore: Shareholders of Mindray Medical, a leading developer, manufacturer and marketer of medical devices, have re-elected its directors Mr Xu Hang, Mr Ronald Ede and Mr Chen Qingtai. E...Read more

  • Life Tech Sanger sequencer gets China SFDA nod

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 Mar, 2013

    Singapore: Life Technologies announced that its Applied Biosystems 3500xL Dx Genetic Analyzer has been approved by China's State Food and Drug Administration (SFDA) for clinical diagnostic...Read more

  • EntreMed gets funding from China investors

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2013

    Singapore: EntreMed, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, has received commitments from two China-based investors, including institut...Read more

  • China Nepstar disposes 40% equity ownership in Yunnan Jianzhijia

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: China Nepstar Chain Drugstore has completed the sales of its 40 percent equity ownership in Yunnan Jianzhijia Chain Drugstore Ltd. (JZJ) to Yunnan Jianzhijia Holding (JZJ Holding...Read more

  • China vigilant on drug price policy

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: A team of China's National Health and Family Planning Commission (NHFPC) led by Mr Li Xi, head, Permanent Discipline Inspection Group, China, have visited sites in Jiangsu, Anhui...Read more

  • Parexel opens its 6th office in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2013

    Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client demand for a broad range of clinical development capabilities in the count...Read more

  • ShangPharma celebrates 10 years with Eli Lilly

    China |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

    Singapore: ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, celebrated the 10th anniversary of its partnership with Eli Lilly. "I a...Read more

  • Top 20 APAC Country Analysis: Korea

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2015

    Singapore: South Korea is the fourth largest contributor to the lifescience market in the region. • Korean Ministry of Food and Drug Safety (MFDS) stated that medicine exports of th...Read more

  • A time to rethink talent management

    China |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

            Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It tested their skills to keep pace with the high level of investment and ...Read more

  • John Crowley is Charles River's CAO

    China |  Influencers | By BioSpectrum Bureau  | 0 Comment | 27 Sep, 2013

    Singapore: Charles River Laboratories has appointed Mr John Crowley to the role of corporate senior VP, corporate controller and chief accounting officer (CAO), effective September 30, 2013...Read more

  • Zhejiang Medicine, Ambrx to develop antibody drug conjugate for breast cancer

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced interna...Read more

  • Innovative way to meet the global HSA requirement

    China |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2012

    Human serum albumin (HSA), a blood protein that is widely used in drug and vaccine production, is in high demand around the world. The primary source of the HSA is donated human blood, whic...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls